Skip to content

    Trevi Therapeutics (TRVI) stock price & financials

    View TRVI earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+109.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    Operating Profit
    -$14.09M
    -$12.24M
    -$11.47M
    -$13.72M
    -$13.92M
    +1.2%
    -$10.22M
    +16.5%
    -$14.91M
    -30.0%
    -$20.51M
    -49.5%
    Weakening
    Net Profit
    -$13.24M
    -$11.41M
    -$10.34M
    -$12.30M
    -$11.80M
    +10.9%
    -$8.32M
    +27.1%
    -$13.19M
    -27.6%
    -$17.80M
    -44.7%
    Weakening
    EPS
    $-0.13
    $-0.09
    $-0.09
    $-0.08
    +38.5%
    $-0.09
    +0.0%
    $-0.11
    -22.2%
    Weakening
    Other Income
    $814.0K
    $844.0K
    $1.12M
    $1.40M
    $2.10M
    +157.9%
    $1.89M
    +123.6%
    $1.70M
    +51.9%
    $2.69M
    +92.4%
    Strengthening
    Interest
    $1.0K
    $1.0K
    $0
    $0
    -100.0%
    Depreciation
    Profit before Tax
    -$13.27M
    -$11.40M
    -$10.35M
    -$12.32M
    -$11.82M
    +11.0%
    -$8.33M
    +26.9%
    -$13.21M
    -27.6%
    -$17.82M
    -44.6%
    Weakening
    MarginsOPM
    Tax
    0.2%
    -0.1%
    0.1%
    0.2%
    0.1%
    -43.5%
    0.2%
    0.1%
    +36.4%
    0.1%
    -35.3%
    Stable
    ReturnsROIC
    2.1%
    1.8%
    1.7%
    2.0%
    1.9%
    -10.9%
    1.3%
    -27.1%
    2.1%
    +27.6%
    2.8%
    +44.7%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$7.20M$57.31M$45.00M$36.83M$12.59M$32.40M$34.10M$18.91M$54.30M
    Short-Term Investments$107.92M$50.57M$73.53M$169.35M$264.57M
    Total Current Assets$8.82M$59.55M$46.27M$37.96M$122.62M$87.55M$109.43M$191.66M$325.70M
    Net PP&E$149.0K$430.0K$330.0K$184.0K$194.0K$1.35M$1.07M$855.0K$878.0K
    Goodwill
    Intangibles
    Total Assets$10.53M$60.00M$47.13M$38.48M$123.02M$89.40M$110.90M$193.44M$330.52M
    LiabilitiesTotal Current Liabilities$2.68M$5.20M$5.55M$12.72M$13.40M$5.82M$10.51M$9.75M$8.74M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$46.0K$257.0K$144.0K$24.0K$2.0K$1.00M$747.0K$446.0K$276.0K
    Total Liabilities$120.02M$5.46M$19.85M$21.40M$15.56M$6.86M$11.26M$10.20M$9.01M
    EquityCommon Stock & APIC$4.0K$18.0K$19.0K$29.0K$60.0K$68.0K$94.0K$128.0K$142.0K
    Retained Earnings-$109.50M-$114.22M-$146.98M-$180.92M-$210.07M-$239.13M-$287.05M-$329.80M-$360.79M
    Total Equity-$109.49M$54.55M$27.28M$17.07M$107.46M$82.55M$99.64M$183.24M$321.51M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$18.29M-$23.09M-$29.00M-$28.95M-$28.18M-$31.71M-$38.26M-$42.09M-$52.63M
    Cash from Investing-$158.0K-$9.0K-$32.0K-$107.37M$59.43M-$21.53M-$94.11M-$176.62M
    Cash from Financing$3.63M$73.21M$16.72M$20.77M$111.31M-$7.91M$61.48M$121.01M$166.49M
    SummaryCapital Expenditure-$158.0K-$9.0K-$32.0K-$159.0K-$137.0K-$35.0K-$12.0K-$238.0K
    Free Cash Flow-$18.45M-$23.10M-$29.03M-$28.33M-$31.85M-$38.29M-$42.10M-$52.87M
    FCF Margin

    Ratios